RYLPF News and Press, Koninklijke Philips NV From 02/28/24

February 28, 2024 Proposal to appoint Ms. Hanneman as member of Philips’ Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announce...

February 27, 2024 New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX...

February 20, 2024 1.88 billion lives improved by Philips’ health technology products and services; on track to improve 2 billion lives by 2025 Through its industry leading innovations and partnerships, Philips helps increase access to healthcare globally and create sust...

February 20, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it proposes to re-appoint Chairman Feike Sijbesma and Peter Löscher as members of the Supervisory Board and to appoint Beno&#...

February 20, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2023. Philips’ Annual Report 2023 will be on the agenda of the Annual General Meeting of Shareholders (AGM), t...

February 6, 2024 FDA 510(k) clearance of latest Philips IntelliVue patient monitor software helps drive alarm management strategies toward a more peaceful, healing environment for patients and caregivers Amsterdam, the Netherlands – Advances in healthcare technology continu...

January 31, 2023 Latest innovation has the potential to reduce anesthesia during minimally invasive procedures [1] As a pioneer and leading innovator in cardiac ultrasound, Philips has developed the smaller X11- 4t Mini 3D TEE transducer to serve more patients with this valuable i...

2024-01-29 12:49:51 ET More on ResMed ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript ResMed Inc. 2024 Q2 - Results - Earnings Call Presentation Why ResMed Is One Of My Top Picks In 2024 ResMed jumps 9% as quarterly results shine ResMed Q2 2024 Ear...

2024-01-29 07:31:02 ET Koninklijke Philips N.V. (PHG) Q4 2023 Earnings Conference Call January 29, 2024 04:00 AM ET Company Participants Leandro Mazzoni - Head-Investor Relations Roy Jakobs - Chief Executive Officer Abhijit Bhattacharya - Chief Financial Officer ...

January 29, 2024 Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 plan Agrees with FDA on terms of consent decree focused on Philips Respironics in the US, providing clarity and a roadmap to demonstrate...